HOW IS EQUOL DIFFERENT FROM BPH DRUGS ON THE MARKET?
The most common treatments for BPH are enzyme blocking drugs. These medications work by inhibiting the important 5-alpha reductase enzyme from converting testosterone to DHT. Inhibiting this conversion reduces the amount of DHT available to bind to the prostate gland and therefore helps prevent prostate growth. However, the 5-alpha reductase enzyme plays a role in other important and beneficial functions in the body. Enzyme blockers are useful, in that they prevent the formation of DHT, however, they can also lead to negative side effects by blocking the beneficial enzymatic functions the enzyme performs.
Instead of preventing 5-alpha reductase from converting testosterone to DHT, Equol binds directly with DHT, and thus inhibits DHT from binding to the prostate. This inhibits prostate growth without interfering with the beneficial functions of the 5-alpha reductase enzyme. Consequently, Equol supports the prostate with no known side effects.